Complex Abdominal Wall Reconstruction Using Biologic Mesh

Complex Abdominal Wall Reconstruction Using Biologic Mesh Outcomes Prospective Study

The purpose of this study is to determine how the patient factors, co-morbid conditions, pre-operative workup, anatomy of the defect, reconstruction details, operative techniques, and type of repairs contribute to the final outcome of abdominal wall reconstruction. The outcomes of interest are: in-hospital complications, discharge disposition, hospital and ICU length of stay, long term follow-up (recurrence, reoperation, and explantation rates).

Study Overview

• Status: Unknown
• Conditions: Hernia

Detailed Description

Background:

Abdominal wall defects are commonly seen in trauma and EGS patients. During the last decade numerous advances have been made in the management of patients with abdominal wall defects. These defects are repaired by various surgical techniques including mesh repair (synthetic vs. biologic), primary repair, etc. However, the outcomes of patients after these injuries are highly variable and many of these patients suffer from in-hospital complications, mesh infections requiring explantation, and recurrence. Various factors play a role in the final outcome of the patient. These include factors associated with the initial surgery or disease (trauma or emergency general surgery), patient demographics (age, gender, co-morbidities), preoperative features (hemoglobin and laboratory parameters), technique of repair (onlay, inlay, retro rectus) and the types of mesh used. However, the role of each of these factors in the final outcome of patients remains unclear in the literature.

Study Design Study Type: Observational Observational Study Model: Cohort Time Perspective: Prospective Enrollment: 250 Number of Groups/Cohorts: 1

Recruitment Procedures:

Attending physicians will discuss possible participation in the study with patients who meet initial screening criteria and have been scheduled for abdominal wall repair/ventral hernia repair. If a patient agrees, they will be approached by our research coordinator to discuss consenting. The research coordinator will introduce herself and her role with Westchester Medical Center, and read the following script. A translator for Spanish speaking patients will be available.

Hello, my name is _______________. I am a research coordinator with the Department of Surgery here at Westchester Medical Center. I'm talking to you today because you or your family member are scheduled to have a surgery that involves abdominal wall repair. Dr. Latifi, the Director of the Department of Surgery, is conducting a study looking at outcomes from this surgery. We are interested in how this procedure and personal factors, such as having diabetes, may contribute to how long you stay in the hospital, have a recurrence or develop an infection. Participation in this study does not require anything additional from you. You will receive the same care if you do or do not participate. The only difference is we would maintain your outcome data for analysis purposes. Would you be interested in learning more about the study and discussing study details with me and Dr. Latifi? If so, are you able to meet and when would you like to meet? Or, if you do not know yet, can you provide me with your phone number or the best way to contact you to schedule a follow-up meeting to discuss the study?

Research Coordinator meets and collects potential participant contact information.

Meeting will be held to describe study in more detail and to consent participant and/or representative. If participant is already in the hospital for the procedure, the meeting will be held as soon as possible.

Data management:

The research involves no more than minimal risk to subjects as it provides no additional treatment for patients who had abdominal wall defects and are undergoing surgery. Data will be obtained on their pre and perioperative details, their interventions, and final outcomes. This study will use a chart review of data from electronic medical records for current patients. Subjects will be recruited, consented, and medical record data will be gathered prospectively.

Medical records containing Protective Health Information such as admission and discharge date will be obtained from the hospital Electronic Medical Record database in the form of a query spreadsheet to determine hospital and ICU length of stay. All data will be de-identified using a unique identifier that is assigned to each record.

Data will be queried from the database and kept in a password protected excel spreadsheet. Only the PI and designated research personnel will have the access to the Protective Health Information and data linkage file. The PI designated research team members will have the access to the de-identified data.

Data will be stored and secured in a logbook/secured computer with the PI. Hard copies will also be stored in closed envelopes in locked cabinets in PI's office. The data will be kept for a period of seven years and then later will be destroyed. Data will be stored by the Westchester Medical Center (WMC) Lead PI.

Analytic Plan: Chi-square difference tests will be used to assess significant differences in predictors on categorical outcomes. T-tests will be used to assess mean differences in predictors on continuous outcomes. Univariable and multivariable logistic regression analyses will be conducted for outcomes such as all-cause mortality, pneumonia, sepsis, and multi-organ failure. Univariable and multivariable linear regression will be performed for hospital length of stay.

• Study Type: Observational
• Enrollment (Anticipated): 250

Contacts and Locations

Study Locations

• United States
  • New York
    • Valhalla, New York, United States, 10595
      • Recruiting
      • Westchester Medical Center
      • Principal Investigator: Rifat Latifi, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

All patients aged 18 years and above undergoing Abdominal wall reconstruction with biological mesh irrespective of gender, ethnicity, socio-economic status will be included in the study.

Description

Inclusion Criteria:

• All patients aged 18 years and above undergoing Abdominal wall reconstruction with biological mesh.

Exclusion Criteria:

• Vulnerable patient population (Neonates, Prisoners, Pregnant) will not be included in our study

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
In Hospital Complications	Infection, re-procedures, explantation rates, length of hospital stay and ICU stay.	3 years

Collaborators and Investigators

• Sponsor: New York Medical College

Study record dates

Study Major Dates

• Study Start (Actual): July 7, 2017
• Primary Completion (Anticipated): July 6, 2022
• Study Completion (Anticipated): December 6, 2022

Study Registration Dates

• First Submitted: August 13, 2020
• First Submitted That Met QC Criteria: March 1, 2021
• First Posted (Actual): March 3, 2021

Study Record Updates

• Last Update Posted (Actual): March 3, 2021
• Last Update Submitted That Met QC Criteria: March 1, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Keywords: Hernia repair
• Additional Relevant MeSH Terms: Pathological Conditions, Anatomical; Hernia
• Other Study ID Numbers: L#12086

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: no plans

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No